Rubicon Organics Inc. ROMJ ROMJF reported its third quarter financial results on Tuesday for the three months ended Sept. 30, 2023, revealing a 5% year-over-year increase in revenue to CA$10 million ($7.26 million).
The Canadian cannabis producer also touted a sixth consecutive quarter of adjusted EBITDA profitability with CA$1.1 million in the third quarter, representing a year-over-year decrease of CA$0.8 million.
“Despite the challenges encountered in the demanding Canadian cannabis sector with competitive price compression alongside broader negative macroeconomic pressures faced by Canadian shoppers, we persist in fortifying the company's standing as a leading force in the premium cannabis market, and are looking forward to executing our strategy to leverage the strength of our leading premium brands,” said Margaret Brodie, interim CEO and CFO.
Q3 2023 Financial Highlights
- Gross profit was CA$1.9 million, compared to CA$6 million in the corresponding quarter of last year.
- Achieved fifth consecutive quarter of operating cashflow positive of CA$1.4 million.
- Loss from operations amounted to CA$1.5 million, compared to income from operations of CA$2.2 million in the third quarter of last year.
Nine Months Ended Sept. 30
- Net revenue of CA$30.1 million, up from CA$24.5 million in the same period of 2022.
- Gross profit was CA$9 million, down from CA$11.7 million in the same period of last year.
- Adjusted EBITDA came in positive at CA$3.1 million, compared to CA$641,349 adjusted EBITDA gain in the corresponding period of 2022.
- Loss from operations totaled roughly CA$2 million, compared to CA$128,806 income from operations in the corresponding period of 2022.
- Growth in cash balance by CA$2.6 million from Sept. 30, 2022, from CA$6.8 million to CA$9.4 million.
- The Company had a working capital of CA$18.7 million as of Sept. 30, 2023, of which CA$9.4 million of cash on hand and CA$3.6 million in accounts receivable.
ROMJF Price Action
Rubicon’s shares traded 23.33% lower at $0.345 per share at the time of writing on Wednesday morning.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF
Related News
- Rubicon Organics FY22 Revenue Grows 57% To $26.4M, What About Adjusted EBITDA?
- This Pot Stock Significantly Shrinks Its Quarterly Loss, Sees 28% YoY Revenue Growth, Projects Positive Free Cashflow For Full Year
- Rubicon Organics Q1 Revenue Grows 71% YoY, Thanks To Expansion Of 1964 Supply Co, Here Are The Details
Photo: Courtesy of Elsa Olofsson on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!